About
565.87USD+1.94 +0.34%
Closed • Updated at 02:14 GMT+00:00Market Cap$24.02B
P/E Ratio20.88
Volume420.9K
Beta0.43
RSI48.16
Gross Margin86.58%
United Therapeutics Corporation — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
May 17 2026
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
May 15 2026
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
May 13 2026
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
May 12 2026
United Therapeutics Corporation to Present at the RBC Capital Markets Global Healthcare Conference
Google Übersetzer